{"id":539035,"date":"2021-04-16T20:26:03","date_gmt":"2021-04-16T20:26:03","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=539035"},"modified":"2021-04-16T20:26:03","modified_gmt":"2021-04-16T20:26:03","slug":"cluster-headache-market-is-expected-to-grow-at-a-cagr-of-530-for-the-study-period-201830-by-delveinsight-lundbeck-seattle-biopharmaceutical-winston-laboratories-zosano-pharma-and-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/cluster-headache-market-is-expected-to-grow-at-a-cagr-of-530-for-the-study-period-201830-by-delveinsight-lundbeck-seattle-biopharmaceutical-winston-laboratories-zosano-pharma-and-others_539035.html","title":{"rendered":"Cluster Headache Market is expected to grow at a CAGR of 5.30% for the study period 2018-30 by DelveInsight | Lundbeck Seattle BioPharmaceutical, Winston Laboratories, Zosano Pharma and Others"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1585720511.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Cluster Headache Market is expected to grow at a CAGR of 5.30% for the study period 2018-30 by DelveInsight | Lundbeck Seattle BioPharmaceutical, Winston Laboratories, Zosano Pharma and Others\" src=\"https:\/\/www.abnewswire.com\/uploads\/1585720511.jpeg\" alt=\"Cluster Headache Market is expected to grow at a CAGR of 5.30% for the study period 2018-30 by DelveInsight | Lundbeck Seattle BioPharmaceutical, Winston Laboratories, Zosano Pharma and Others\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Cluster Headache Market<\/div>\n<\/div>\n<\/div>\n<p style=\"text-align: justify;\"><strong>Cluster Headaches<\/strong> are an uncommon, severe form of primary neurovascular headaches. It is the most painful form of headaches, with the pain occurring on one side of the head and behind or above the eye or at the temple, most commonly.&nbsp;<\/p>\n<p style=\"text-align: justify;\">Cluster Headache patients have typical trigeminal-autonomic symptoms, such as ptosis, sweating, and miosis. In addition to trigeminal-autonomic symptoms, a large proportion of patients with Cluster Headaches have migraine-like features such as photophobia or osmophobia; thus, many patients are not correctly diagnosed and are misdiagnosed with a migraine disorder instead.<\/p>\n<p style=\"text-align: justify;\">According to DelveInsight&#8217;s analysts, the total prevalent Cluster Headache population in the 7MM countries was estimated to be&nbsp;<strong>877,859<\/strong>&nbsp;cases in 2020. A higher percentage of the male population is affected by Cluster Headache as compared to the female population.&nbsp;<\/p>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s &#8220;<strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/cluster-headache-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\" target=\"_blank\">Cluster Headache Market<\/a><\/strong>&#8221; report provides a thorough comprehension of the Cluster Headache, historical and forecasted epidemiology, and the Cluster Headache market trends in the 7MM [the United States, EU5 (Germany,&nbsp;Spain,&nbsp;Italy,&nbsp;France, and&nbsp;United Kingdom) and&nbsp;Japan]. The Cluster Headache market report also proffers an analysis of the current Cluster Headache treatment algorithm\/practice, market drivers, market barriers, and unmet medical needs.&nbsp;<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>For further information on Market Impact by Therapies, visit:&nbsp;<\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/cluster-headache-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\" target=\"_blank\">Global Cluster Headache Drug Treatment Market&nbsp;<\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key takeaways of the&nbsp;Cluster Headache Market Research Report&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Many patients are undertreated, and in some cases, not treated. Cluster Headache patients are more likely to use prescription and nonprescription pain medications, including opiates.<\/li>\n<li><strong>Verapamil&nbsp;<\/strong>is the first choice drug in the preventive treatment of Cluster Headache. Some of the most promising drugs include&nbsp;<strong>Triptans, Analgesics, Verapamil, Emgality<\/strong>, among others.&nbsp;<\/li>\n<li>The major key players include&nbsp;<strong>Lundbeck Seattle BioPharmaceutical, Winston Laboratories, Zosano Pharma, Eli Lilly and Company,<\/strong>&nbsp;and others that hold the potential to create a significant drag in the Cluster Headache market.<\/li>\n<li>The Cluster Headache market is expected to gain traction, attributed to increased prevalence and the expected launch of novel therapies, such as&nbsp;<strong>Eptinezumab<\/strong>,&nbsp;<strong>Civamide<\/strong>,&nbsp;<strong>Zolmitriptan<\/strong>, and others during the forecast period (2018&ndash;2030). The Cluster Headache market has a promising outlook with the launch of drugs such as&nbsp;<strong>Emgility&nbsp;<\/strong>in 2020, and with emerging drugs such as&nbsp;<strong>Eptinezumab<\/strong>&nbsp;and&nbsp;<strong>Civamide&nbsp;<\/strong>which&nbsp;are expected to enter&nbsp;the United States&nbsp;market by 2024 and 2025 respectively.&nbsp;<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>The&nbsp;Cluster Headache Market Report&nbsp;provides historical as well as forecasted epidemiological analysis segmented into:&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Cluster Headache Prevalence<\/li>\n<li>Cluster Headache Diagnosed Cases&nbsp;<\/li>\n<li>Type-specific Cases of Cluster Headache<\/li>\n<li>Gender-specific Cases of Cluster Headache<\/li>\n<li>Age-specific Cases of Cluster Headache&nbsp;<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong><img decoding=\"async\" style=\"display: block; margin-left: auto; margin-right: auto;\" src=\"https:\/\/www.abnewswire.com\/uploads\/aacd7ce6fc295be55fbee0178128e90f.jpg\" alt=\"\" \/><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Get a sample copy of this report:&nbsp;<\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/cluster-headache-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\" target=\"_blank\">Cluster Headache Market Landscape<\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/cluster-headache-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\" target=\"_blank\">Cluster Headache Emerging Therapies<\/a>&nbsp;Along with Key Players<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>VYEPTI (Eptinezumab): Lundbeck Seattle BioPharmaceutical<\/li>\n<li>Civamide (Zucapsaicin): Winston Laboratories<\/li>\n<li>Zolmitriptan transdermal (C213): Zosano Pharma<\/li>\n<li>And several others.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">To conclude,<strong>&nbsp;<\/strong>Cluster Headache Market Growth<strong>&nbsp;<\/strong>will upsurge due to&nbsp;<strong>the launch of emerging therapies that are better in efficacy and\/or with a more favorable safety profile, development of a genetic approach, and a large cohort of patients<\/strong>. Since the entire landscape was till recently was devoid of any effective pharmaceutical treatment option, any significant development in this direction is expected to create a tectonic impact on the existing market scenario nevertheless,<strong>&nbsp;clinical trials challenges, economic burden, and lack of doctor&#8217;s knowledge regarding the disease<\/strong>&nbsp;will hinder&nbsp;Cluster Headache Market.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for a Webex demo of the report @&nbsp;<\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/cluster-headache-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\" target=\"_blank\">Cluster Headache Treatment Market Size<\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the&nbsp;Cluster Headache Market Insight Report&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Geography Covered: <\/strong>7MM &#8211;&nbsp;The United States, EU5 (Germany,&nbsp;France,&nbsp;Italy,&nbsp;Spain, and the&nbsp;United Kingdom),&nbsp;Japan.<\/li>\n<li><strong>Study Period<\/strong>: 3-year historical and 10-year forecasted analysis (2018-2030).<\/li>\n<li><strong>Cluster Headache&nbsp;Markets Segmentation<\/strong>: By&nbsp;<strong>Geographies<\/strong>&nbsp;and By&nbsp;<strong>Cluster Headache&nbsp;Therapies&nbsp;<\/strong>(Historical and Forecasted, Current and Upcoming)&nbsp;<\/li>\n<li><strong>Dominant Market Companies investigating its candidates for&nbsp;Cluster Headache:<\/strong>&nbsp;Lundbeck Seattle BioPharmaceutical, Winston Laboratories, and Zosano Pharma, Eli Lilly and Company, and several others.<\/li>\n<li><strong>Analysis<\/strong>: Comparative and conjoint analysis of emerging therapies.&nbsp;<\/li>\n<li>Case Studies<\/li>\n<li>KOL&#8217;s Views<\/li>\n<li>Analyst&#8217;s View<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents&nbsp;<\/strong><\/p>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"0\">\n<tbody>\n<tr>\n<td valign=\"bottom\">\n<p><strong>1<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Cluster Headache Key Insights<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>2<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Cluster Headache Report Introduction<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>3<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Cluster Headache Market Overview at a Glance<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>4<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Executive Summary of Cluster Headache&nbsp;<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>5<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Cluster Headache Disease Background and Overview&nbsp;<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>6<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Cluster Headache Epidemiology and Patient Population<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>7<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>7MM Total Diagnosed Cluster Headache Prevalent Population&nbsp;<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>7.1<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>The United States<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>7.2<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>EU5 Countries<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>7.2.1<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>Germany<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>7.2.2<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>France<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>7.2.3<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>Italy<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>7.2.4<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>Spain<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>7.2.5<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>The United Kingdom<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>7.3<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>Japan<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>8<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Cluster Headache Case Reports<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>9<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Cluster Headache Marketed Products<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>9.1<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>EMGALITY (Galcanezumab-gnlm): Eli Lilly and Company<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>10<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Cluster Headache Emerging Drugs<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>10.1<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>VYEPTI (Eptinezumab): Lundbeck Seattle BioPharmaceutical<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>10.2<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>Civamide (Zucapsaicin): Winston Laboratories<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>11<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Other Cluster Headache Drugs under Development<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>11.1<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>Zolmitriptan transdermal (C213): Zosano Pharma<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>12<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>7MM Cluster Headache Market Analysis<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>12.1<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>The United States Cluster Headache Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>12.2<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>EU-5 Cluster Headache Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>12.2.1<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>Germany Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>12.2.2<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>France Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>12.2.3<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>Italy Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>12.2.4<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>Spain Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>12.2.5<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>The United Kingdom Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p>12.3<\/p>\n<\/td>\n<td valign=\"bottom\">\n<p>Japan Cluster Headache Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>13<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>KOL Views<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>14<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Cluster Headache Market Drivers<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>15<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Cluster Headache Market Barriers<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>16<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>SWOT Analysis of Cluster Headache<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>17<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Cluster Headache Unmet Needs<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>18<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Cluster Headache Market Access<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>19<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Appendix<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>20<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>DelveInsight Capabilities<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>21<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>Disclaimer<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td valign=\"bottom\">\n<p><strong>22<\/strong><\/p>\n<\/td>\n<td valign=\"bottom\">\n<p><strong>About DelveInsight<\/strong><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"text-align: justify;\"><strong>Browse full report with detailed TOC with charts, figures, tables @&nbsp;<\/strong>Cluster Headache Treatment Market Report<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About&nbsp;DelveInsight<\/strong><br \/> DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=cluster-headache-market-is-expected-to-grow-at-a-cagr-of-530-for-the-study-period-201830-by-delveinsight-lundbeck-seattle-biopharmaceutical-winston-laboratories-zosano-pharma-and-others\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +19193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/report-store\/cluster-headache-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/report-store\/cluster-headache-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/report-store\/cluster-headache-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=cluster-headache-market-is-expected-to-grow-at-a-cagr-of-530-for-the-study-period-201830-by-delveinsight-lundbeck-seattle-biopharmaceutical-winston-laboratories-zosano-pharma-and-others\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cluster Headache Market Cluster Headaches are an uncommon, severe form of primary neurovascular headaches. It is the most painful form of headaches, with the pain occurring on one side of the head and behind or above the eye or at &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/cluster-headache-market-is-expected-to-grow-at-a-cagr-of-530-for-the-study-period-201830-by-delveinsight-lundbeck-seattle-biopharmaceutical-winston-laboratories-zosano-pharma-and-others_539035.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,417,406,423,413],"tags":[],"class_list":["post-539035","post","type-post","status-publish","format-standard","hentry","category-Business","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services","category-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/539035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=539035"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/539035\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=539035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=539035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=539035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}